Cyteir Therapeutics, Inc. Common Stock
CYT
CYT was delisted on the 15th of March, 2024.
38 hedge funds and large institutions have $344M invested in Cyteir Therapeutics, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 11 increasing their positions, 6 reducing their positions, and 14 closing their positions.
83% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 6
36% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 14
15% more funds holding
Funds holding: 33 → 38 (+5)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
2% less capital invested
Capital invested by funds: $353M → $344M (-$8.51M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$60.3M |
| 2 |
BlackRock
New York
|
+$7.32M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.07M |
| 4 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$2.13M |
| 5 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$1.93M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ABG
Ally Bridge Group
New York
|
-$5.74M |
| 2 |
SCM
Suvretta Capital Management
New York
|
-$3.75M |
| 3 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$3.1M |
| 4 |
Millennium Management
New York
|
-$2.96M |
| 5 |
HM
HealthCor Management
New York
|
-$2.57M |
CYT Hedge Fund Activity: Q3 2021 in Review
38 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Cyteir Therapeutics, Inc. Common Stock (CYT) for Q3 2021, worth a combined $344M — down 2.4% from $353M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new CYT positions and 14 closed out — a net gain of 5 holders — while 11 added to existing stakes and 6 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $60.3M. The largest seller was Ally Bridge Group, cutting an estimated $5.74M.
- 38 institutional investors held Cyteir Therapeutics, Inc. Common Stock (CYT) as of Q3 2021, up from 33 in Q2 2021.
- Funds reported $344M of Cyteir Therapeutics, Inc. Common Stock stock for Q3 2021, down 2.4% quarter-over-quarter.
- 19 funds opened new Cyteir Therapeutics, Inc. Common Stock positions in Q3 2021 and 14 closed out, a net change of +5 holders.
- The largest Cyteir Therapeutics, Inc. Common Stock buyer in Q3 2021 was Fidelity Investments, an estimated $60.3M added.
- The largest Cyteir Therapeutics, Inc. Common Stock seller in Q3 2021 was Ally Bridge Group, an estimated $5.74M sold.
Based on aggregated 13F filings for Q3 2021.